APA (7th ed.) Citation

N, V., BP, N., G, B., D, W., S, S., D, W., . . . AVS, H. (2019). Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. The Journal of infectious diseases, 219(8), 1187. https://doi.org/10.1093/infdis/jiy639

Chicago Style (17th ed.) Citation

N, Venkatraman, et al. "Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal." The Journal of Infectious Diseases 219, no. 8 (2019): 1187. https://doi.org/10.1093/infdis/jiy639.

MLA (9th ed.) Citation

N, Venkatraman, et al. "Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal." The Journal of Infectious Diseases, vol. 219, no. 8, 2019, p. 1187, https://doi.org/10.1093/infdis/jiy639.